Portage Biotech Inc. Announces Change in Certifying Accountant Amid IT Control Weaknesses

Reuters05-30

<a href="https://laohu8.com/S/PRTG">Portage Biotech Inc.</a> Announces Change in Certifying Accountant Amid IT Control Weaknesses

Portage Biotech Inc. has announced a change in its independent registered accounting firm. On May 29, 2025, Marcum LLP resigned from its role, and CBIZ CPAs P.C. was appointed as the new auditor with the approval of the company's Audit Committee. This change follows CBIZ CPAs' acquisition of Marcum's attest business on November 1, 2024. During the fiscal years ending March 31, 2022, 2023, and 2024, Portage Biotech reported no disagreements with Marcum on accounting principles or practices. However, a material weakness was identified regarding the company's information technology general controls, such as privileged access rights and user access reviews, which could potentially lead to inappropriate financial transactions. These issues were disclosed in the company's annual report and are being addressed to ensure effective financial controls.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Portage Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171843-25-003519), on May 29, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2539295474?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-30 04:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2539295474","market":"nz","top_or_hot":-1,"title":"Portage Biotech Inc. Announces Change in Certifying Accountant Amid IT Control Weaknesses","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/PRTG\">Portage Biotech Inc.</a> Announces Change in Certifying Accountant Amid IT Control Weaknesses\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Portage Biotech Inc. has announced a change in its independent registered accounting firm. On May 29, 2025, Marcum LLP resigned from its role, and CBIZ CPAs P.C. was appointed as the new auditor with the approval of the company's Audit Committee. This change follows CBIZ CPAs' acquisition of Marcum's attest business on November 1, 2024. During the fiscal years ending March 31, 2022, 2023, and 2024, Portage Biotech reported no disagreements with Marcum on accounting principles or practices. However, a material weakness was identified regarding the company's information technology general controls, such as privileged access rights and user access reviews, which could potentially lead to inappropriate financial transactions. These issues were disclosed in the company's annual report and are being addressed to ensure effective financial controls.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Portage Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171843-25-003519), on May 29, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Portage Biotech Inc. Announces Change in Certifying Accountant Amid IT Control Weaknesses</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPortage Biotech Inc. Announces Change in Certifying Accountant Amid IT Control Weaknesses\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-05-30 04:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/PRTG\">Portage Biotech Inc.</a> Announces Change in Certifying Accountant Amid IT Control Weaknesses\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Portage Biotech Inc. has announced a change in its independent registered accounting firm. On May 29, 2025, Marcum LLP resigned from its role, and CBIZ CPAs P.C. was appointed as the new auditor with the approval of the company's Audit Committee. This change follows CBIZ CPAs' acquisition of Marcum's attest business on November 1, 2024. During the fiscal years ending March 31, 2022, 2023, and 2024, Portage Biotech reported no disagreements with Marcum on accounting principles or practices. However, a material weakness was identified regarding the company's information technology general controls, such as privileged access rights and user access reviews, which could potentially lead to inappropriate financial transactions. These issues were disclosed in the company's annual report and are being addressed to ensure effective financial controls.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Portage Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171843-25-003519), on May 29, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2065732104.USD","symbol_name":"ALLSPRING (LUX) WF GLOBAL SMALL CAP EQUITY \"I\" (USD) ACC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nNDL7qHM1C:1","article_id":"2539295474","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2539295474","pubTimestamp":1748550646,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Portage Biotech Inc. has announced a change in its independent registered accounting firm. On May 29, 2025, Marcum LLP resigned from its role, and CBIZ CPAs P.C. was appointed as the new auditor with the approval of the company's Audit Committee. This change follows CBIZ CPAs' acquisition of Marcum's attest business on November 1, 2024. During the fiscal years ending March 31, 2022, 2023, and 2024, Portage Biotech reported no disagreements with Marcum on accounting principles or practices. However, a material weakness was identified regarding the company's information technology general controls, such as privileged access rights and user access reviews, which could potentially lead to inappropriate financial transactions. These issues were disclosed in the company's annual report and are being addressed to ensure effective financial controls.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2065732104.USD":"ALLSPRING (LUX) WF GLOBAL SMALL CAP EQUITY \"I\" (USD) ACC","CBZ":"CBIZ Inc","BK4123":"调查和咨询服务","BK4139":"生物科技"},"translate_title":"Portage Biotech Inc.宣布因IT控制弱点而更换注册会计师","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PRTG":0.9,"CBZ":0.9},"content_text":"Portage Biotech Inc. Announces Change in Certifying Accountant Amid IT Control Weaknesses\n    \n\n        Portage Biotech Inc. has announced a change in its independent registered accounting firm. On May 29, 2025, Marcum LLP resigned from its role, and CBIZ CPAs P.C. was appointed as the new auditor with the approval of the company's Audit Committee. This change follows CBIZ CPAs' acquisition of Marcum's attest business on November 1, 2024. During the fiscal years ending March 31, 2022, 2023, and 2024, Portage Biotech reported no disagreements with Marcum on accounting principles or practices. However, a material weakness was identified regarding the company's information technology general controls, such as privileged access rights and user access reviews, which could potentially lead to inappropriate financial transactions. These issues were disclosed in the company's annual report and are being addressed to ensure effective financial controls.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Portage Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171843-25-003519), on May 29, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"event","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2539295474","isCrawlerRequest":true}